Tandem Diabetes Care, Inc. TNDM
Set alert
17.94 USD -0.73 -3.91%
As of Nov 3, 12:06 PM ET
17.90 Day range 18.67
12.26 52-week range 29.65
- YTD
- -18.38%
- 1 year
- +24.93%
- Open
- 18.67
- Prev close
- 18.67
- Mkt cap
- 1.25B
- Vol
- 624.27K
- Avg vol
- 2.13M
- EPS
- -0.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.90
- High
- 18.67
- Forward P/E
- 117.45
- Beta
- 1.59
- Short ratio
- 6.27
- Inst. own
- 115.77%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 18.02
- 200-d avg
- 18.93
- 1y target
- 27.76
Analyst view
Consensus: buy
Buy
Price target (mean) 27.76 +54.7% upside
Now 17.94
- Target (low)
- 18.00
- Target (mean)
- 27.76
- Target (high)
- 50.00
Ratings (0m) 25 13 buy · 12 hold · 0 sell
- Strong buy2
- Buy11
- Hold12
- Sell0
- Strong sell0
Recommendation trend
- This month 25
- 1 month ago 24
- 2 months ago 24
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.2402 | -0.36 – -0.16384 | -0.31 | +22.5% | 265.85M | +6.7% | 20 |
| Next quarter | 0.17934 | 0.02 – 0.32 | -0.01 | +1893.4% | 304.37M | +4.8% | 20 |
| Current year | -0.66392 | -0.91 – -0.4541 | -2.58 | +74.3% | 1.07B | +5.7% | 21 |
| Next year | 0.15896 | -0.30 – 0.57 | -0.66392 | +123.9% | 1.20B | +12.4% | 21 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 7, 2026 | Barclays | Initiated | — | Equal-Weight |
| Sep 30, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Sep 24, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 21, 2026 | William Blair | Initiated | — | Outperform |
| Aug 7, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 15, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Jun 23, 2026 | Deutsche Bank | Initiated | Buy | Hold |
| Jun 1, 2026 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| May 28, 2026 | Citigroup | Maintained | Neutral | Neutral |
| May 18, 2026 | B of A Securities | Maintained | Neutral | Neutral |
| May 12, 2026 | Benchmark | Initiated | — | Hold |
| May 11, 2026 | Truist Securities | Reiterated | Buy | Buy |
| May 11, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 20, 2026 | TD Cowen | Maintained | Buy | Buy |
| Apr 9, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Mar 19, 2026 | Truist Securities | Upgrade | Hold | Buy |
| Mar 17, 2026 | Piper Sandler | Upgrade | Neutral | Overweight |
| Mar 2, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Feb 23, 2026 | Lake Street | Upgrade | Hold | Buy |
| Feb 23, 2026 | Truist Securities | Reiterated | Hold | Hold |
| Feb 20, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Feb 20, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 20, 2026 | Stifel | Maintained | Hold | Hold |
| Feb 20, 2026 | B of A Securities | Upgrade | Underperform | Neutral |
| Feb 20, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Feb 4, 2026 | Stifel | Maintained | Hold | Hold |
| Jan 9, 2026 | Bernstein | Maintained | Market Perform | Market Perform |
| Dec 18, 2025 | Truist Securities | Maintained | Hold | Hold |
| Dec 17, 2025 | Canaccord Genuity | Maintained | Buy | Buy |